Oncolytic virus therapy for mesothelioma - a phase I trial of intrapleural seprehvir

被引：0
|
作者：
Woll, P. J. [1 ]
Danson, S. J. [1 ]
Edwards, J. G. [1 ]
Fisher, P. M. [1 ]
Conner, J. [1 ]
机构：
[1] Univ Sheffield, Sheffield Teaching Hosp & Virttu Biol, Sheffield S10 2TN, S Yorkshire, England
来源：
LUNG CANCER | 2013年 / 79卷
关键词：
D O I：
10.1016/S0169-5002(13)70098-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [31] Oncolytic virus therapy - Foreword
    Kasuya, H.
    Takeda, S.
    Shimoyama, S.
    Shikano, T.
    Nomura, N.
    Kanazumi, N.
    Nomoto, S.
    Sugimoto, H.
    Nakao, A.
    CURRENT CANCER DRUG TARGETS, 2007, 7 (02) : 123 - 125
  • [32] Lymphomas and oncolytic virus therapy
    Alain, T
    Thirukkumaran, C
    Morris, DG
    Urbanski, SJ
    Janowska-Wieczorek, A
    Lee, PWK
    Kossakowska, AE
    CLINICAL LYMPHOMA, 2003, 4 (02): : 104 - 111
  • [33] A PHASE I TRIAL OF INTRAVENOUS ONCOLYTIC REOLYSIN® IN PATIENTS WITH BRAIN TUMOURS
    Jebar, A.
    West, E.
    Scott, K.
    Thomson, S.
    Corns, R.
    Mathew, R.
    SivaKumar, G.
    Coffey, M.
    Nuovo, G.
    Rose, A.
    Ralph, C.
    Twelves, C.
    Anthoney, A.
    Griffin, S.
    Short, S.
    Melcher, A.
    NEURO-ONCOLOGY, 2014, 16
  • [34] Oncolytic virus therapy for cancer
    Goldufsky, Joe
    Sivendran, Shanthi
    Harcharik, Sara
    Pan, Michael
    Bernardo, Sebastian
    Stern, Richard H.
    Friedlander, Philip
    Ruby, Carl E.
    Saenger, Yvonne
    Kaufman, Howard L.
    ONCOLYTIC VIROTHERAPY, 2013, 2 : 31 - 46
  • [35] Intrapleural photodynamic therapy for malignant pleural mesothelioma: A new dosimetry approach
    Munck, Camille
    Scherpereel, Arnaud
    Dhalluin, Xavier
    Porte, Henri
    Mordon, Serge
    Betrouni, Nacim
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [36] Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
    Achard, Carole
    Boisgerault, Nicolas
    Delaunay, Tiphaine
    Roulois, David
    Nedellec, Steven
    Royer, Pierre-Joseph
    Pain, Mallory
    Combredet, Chantal
    Mesel-Lemoine, Mariana
    Cellerin, Laurent
    Magnan, Antoine
    Tangy, Frederic
    Gregoire, Marc
    Fonteneau, Jean-Francois
    ONCOTARGET, 2015, 6 (42) : 44892 - 44904
  • [37] A phase I clinical trial of adenoviral-mediated herpes simplex virus thymidine kinase gene therapy for malignant mesothelioma: Preliminary results.
    Sterman, DH
    Treat, J
    Elshami, AA
    Amin, K
    MolnarKimber, K
    Coonrod, LE
    Recio, A
    Wilson, JM
    Roberts, JR
    Litzky, LA
    Albelda, SM
    Kaiser, LR
    CANCER GENE THERAPY, 1996, 3 (06) : O72 - O72
  • [38] Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma
    Willmon, Candice L.
    Saloura, Vassiliki
    Fridlender, Zvi G.
    Wongthida, Phonphimon
    Diaz, Rosa Maria
    Thompson, Jill
    Kottke, Timothy
    Federspiel, Mark
    Barber, Glen
    Albelda, Steven M.
    Vile, Richard G.
    CANCER RESEARCH, 2009, 69 (19) : 7713 - 7720
  • [39] Phase I trial of adjuvant pembrolizumab after radiation therapy for lung-intact malignant pleural mesothelioma
    Ning, M. S.
    Gandhi, S.
    Gomez, D. R.
    Chang, J. Y.
    Blumenschein, G.
    Rice, D.
    O'Reilly, M.
    Sepesi, B.
    Lin, S. H. H.
    Liao, Z.
    Le, X.
    Byers, L. A.
    Mehran, R.
    Hofstetter, W.
    Hernandez, M.
    Chen, Y-S.
    Jeter, M.
    Tsao, A. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S1115 - S1115
  • [40] DENDRITIC CELL THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM): FINAL RESULTS OF A PHASE I/II CLINICAL TRIAL
    Saevels, K.
    Anguille, S.
    Van de Velde, A.
    Snoeckx, A.
    Van Meerbeeck, J.
    Van den Wijngaert, T.
    Lion, E.
    Stein, B.
    Nijs, G.
    Huizing, M.
    Van Tendeloo, V.
    Germonpre, P.
    Smits, E.
    Berneman, Z.
    HAEMATOLOGICA, 2016, 101 : 121 - 121
12345